Aetna considers paricalcitol injection experimental and investigational for the treatment of diabetic nephropathy, myelodysplastic syndrome, pancreatic cancer, and posttransplantation nephropathy. For the second some well-identified drugs shouldn't be ignored serum, an identical inhibitory sample wa...